Trial Profile
A Randomized, Open Label Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Oct 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 11 Oct 2016 Status changed from not yet recruiting to completed.
- 05 May 2014 New trial record